antidiabetic drugs
Results Trial description recap V1

Albiglutide - Alogliptin - Canagliflozin - Dapagliflozin - Empagliflozin - Exenatide - Glipizide - Glyburide - Liraglutide - Lixisenatide - Metformin - Nateglinide - Pioglitazone - Rosiglitazone - Saxagliptin - Sitagliptin - Sulfonylurea - Taspoglutide - Troglitazone - Voglibose

Diabetes type 2

Type 1 and 2 diabetes 0 trials

all types of patients 91 trials

Type 1 diabetes 0 trials

patients inadequately controlled on metformin 29 trials

Patients inadequately controlled on MET+SU therapy 8 trials

patients with insufficient glycaemic control with bitherapy 16 trials

patients inadequately controlled on monotherapy 56 trials

patients inadequately controlled with insulin 17 trials

in patients inadequately controlled on standard therapy 1 trials

patients inadequately controlled on TZD 3 trials

drug naïve patients 5 trials

patients insufficiently controlled on SU 2 trials